Changeflow GovPing Pharma & Drug Safety EPO Patent Publication EP3390433A1: Novel Cytok...
Routine Notice Added Final

EPO Patent Publication EP3390433A1: Novel Cytokine Fusion Proteins

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Peptides (C07K)
Published March 11th, 2026
Detected March 25th, 2026
Email

Summary

The European Patent Office has published patent application EP3390433A1 for BioNTech SE, detailing novel cytokine fusion proteins. This publication is part of the EPO Bulletin and relates to advancements in peptide technology.

What changed

The European Patent Office (EPO) has published patent application EP3390433A1, filed by BioNTech SE and TRON, concerning "Novel Cytokine Fusion Proteins." This publication, dated March 11, 2026, falls under the C07K classification for peptides and relates to potential therapeutic applications in areas such as oncology, inflammation, and immune response.

This is a patent publication, not a regulatory rule or guidance. It does not impose new compliance obligations on regulated entities. However, it signifies potential future intellectual property developments in the biopharmaceutical sector, which may be of interest to companies involved in drug development and manufacturing.

Source document (simplified)

← EPO Patent Bulletin

NOVEL CYTOKINE FUSION PROTEINS

Publication EP3390433A1 Kind: A1 Mar 11, 2026

Applicants

BioNTech SE, TRON - Translationale Onkologie an der
Universitätsmedizin der Johannes Gutenberg-
Universität Mainz gemeinnützige GmbH

Inventors

SAHIN, Ugur, GIESEKE, Friederike, KREITER, Sebastian, DIKEN, Mustafa

IPC Classifications

A61K 38/00 20060101AFI20250509BHEP A61P 3/00 20060101ALI20250509BHEP A61P 29/00 20060101ALI20250509BHEP A61P 31/00 20060101ALI20250509BHEP A61P 35/00 20060101ALI20250509BHEP A61P 37/06 20060101ALI20250509BHEP A61P 43/00 20060101ALI20250509BHEP C07K 14/54 20060101ALI20250509BHEP C07K 14/705 20060101ALI20250509BHEP C12N 15/62 20060101ALI20250509BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Novel Cytokine Fusion Proteins

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3390433A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Intellectual Property
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.